Chair: Reig Jofre Investments SL, represented by Mrs. Isabel Reig Lopez
Vicepresident: Mr. Alejandro Garcia Reig
CEO: Mr. Ignasi Biosca Reig
Proprietary director: Mr. Álvaro Ybarra Zubiria representing Onchena, SL
Independent director: Mrs. Mª Luisa Francoli Plaza
Independent director: Mr. Ramon Gomis I de Barbara
Independent director: Mr. Ramiro Martinez-Pardo del Valle
Independent director: Mr. Emilio Moraleda Martinez
Non-director secretary: Mr. Adolf Rousaud Viñas
Mrs. Isabel Reig Lopez

Proprietary director representing Reig Jofre Investments, SL – Chair
Appointment: December 31, 2014

Education

  • Degree in Pharmacy from the University of Barcelona

Professional experience

  • Since 2009, Chair of the Board of Directors of Reig Jofre
  • From 1971 to 2010, Technical Director of Reig Jofre until her retirement
  • In 1964 joined the pharmaceutical laboratory Reig Jofre founded by his father

Equity stake in Laboratorio Reig Jofre SA

  • 48,164,321 shares (62.71%) through Reig Jofre Investment SL
Mr. Alejandro Garcia Reig

Proprietary director representing Reig Jofre Investments, SL – Vicepresident
Appointment: November 7, 2017

Education

  • Degree in Business Science from the University of Barcelona

Professional experience

  • Since 2017, Vicepresident of Reig Jofre
  • From 1995 to 2017, Financial Manager at Reig Jofre
  • In 1992 joined the Department of Administration, Accounting and Finance at Reig Jofre

Equity stake in Laboratorio Reig Jofre SA

  • 48,164,321 shares (62.71%) through Reig Jofre Investment SL
Mr. Ignasi Biosca Reig

Executive director – CEO
Appointment: December 31, 2014

Education

  • Telecommunications Engineer from the Polytechnic University of Catalonia (spain)
  • Master in Programming and Networking for Telecom Paris Tech. (France)
  • MBA from IESE Business School (Spain) and University of California, Berkeley (USA)

Professional experience

  • Since 2006, CEO of Reig Jofre
  • From 2014 to 2018, Chairman at Catalonio Bio
  • From 2000 to 2006, CEO at Media Contacts, digital advertising division of Havas Media Group

Equity stake in Laboratorio Reig Jofre SA

  • 48,164,321 shares (62.71%) through Reig Jofre Investment SL
Mr. Álvaro Ybarra Zubiria

Proprietary director representing Onchena, SL
Appointment: July 23, 2020

Education

  • Degree in Economics and Business from the University of País Vasco

Professional experience

  • Member of the Board and member of the Strategy and Appointments and Remuneration Committee at VOCENTO, S.A.
  • President of ONCHENA, S.L.
  • President and founding partner of ALWAYS Sports Management, S.L.
  • Deputy Director General of Planning at Sener Engineering and Systems (Bilbao)
  • Consulting Partner at ASFIN Asesores Financieros (Madrid)
  • Founding partner and CEO at COFIBER, S.A. financing entity
  • Executive President at COFIBER, S.A. financing entity
  • Chief Financial Officer at GRUPO BERGE
  • President of Bodegas Castillo de Cuzcurrita, S.L.
  • President of ISOFOTON, S.A.

Equity stake in Laboratorio Reig Jofre SA

  • 4,477,490 shares (5.8%) through Onchena SL
Mrs. Mª Luisa Francoli Plaza

Independent director
Appointment: December 31, 2014

Education

  • Degree in Economics at the University of Barcelona
  • MBA in Finance at the University of St. John, New York (USA)

Professional experience

  • Member of the advisory committee in several start-ups in Spain and the USA, 2013-2014
  • Member of the board of directors of Oak House Barcelona
  • CEO of Havas Media North America, 2004-2013
  • Founder and CEO of Media Contacts, 1997-2004
  • Director of corporate development in Media Planning, 1993-1996

Equity stake in Laboratorio Reig Jofre SA

  • 7,792 shares (0.01%)
Mr. Ramon Gomis I de Barbara

Independent director
Appointment: December 31, 2014

Education

  • Degree in Medicine
  • PhD in Medicine from the University of Barcelona
  • Postdoctoral training at the Free University of Brussels in endocrinology and obesity
  • Professor of Endocrinology

Professional experience

  • Chairman of the Board of the Spanish Society of Diabetes (SED) (2014 – present)
  • Professor of Medicine at the University of Barcelona (2011 – present)
  • Director of the Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) (2008 – present)
  • Senior consultant, Department of Endocrinology of the Clinic Hospital, Barcelona (1996 – present)
  • Member of international advisory board of diabetes products in Merck
  • Member of national advisory board of diabetes products in Boehringer
Mr. Ramiro Martinez-Pardo del Valle

Independent director
Appointment: December 31, 2014

Education

  • Degree in Economics and Business from the Complutense University of Madrid
  • Chartered Accountant, member of the Institute of Chartered Accountants of Spain
  • Degree in Law from the Complutense University of Madrid

Academic activities

  • Professor in various masters and postgraduate degrees on stock markets, financial law, ethics and codes of conduct, prevention of money laundering

Professional experience

  • He is currently a member of the board of the following companies:
    • Audax Renovables SA
    • Laboratorio Reig Jofre
  • He was a member of the board of directors in companies such as:
    • Eurodeal, SV
    • Banco Madrid Asset Management UCITS
    • Managing company of the investment guarantee fund
    • Nordkapp Gestión, SGIIC. Chairman and CEO until 11/2012
  • Director of development and division director of the market members of CNMV (Spanish Stock Exchange Comimssion), May 1989-September 2000
Mr. Emilio Moraleda Martinez

Independent director
Appointment: December 31, 2014

Education

  • Degree in Law from the Complutense University of Madrid
  • Diplomas in Human Resources and Business Administration from the Universities of Columbia and Harvard (USA)
  • Degree in Social Sciences by the Social Sciences School of Madrid

Professional experience

  • He is currently a member of the board of the following companies:
    • Bionaturis
    • Audax Renovables SA
    • Laboratorio Reig Jofre

Another prior experience

  • Director of human resources at Pfizer, Pechiney Ugine Kuhlmann and Graphic Arts Toledo, SA (Grupo Mondadori Internacional)
  • Commercial director at Pfizer, responsible for sales and training of the pharmaceutical division
  • Executive director of the pharmaceutical division of Pfizer
  • Chairman and CEO of Pfizer Spain
  • Since its creation in 1998 to date, president of the Pfizer Foundation
Audit, Compliance, and Conflicts of Interest committee
Chairman: Mr. Ramiro Martinez-Pardo del Valle
Secretary: Mr. Ramon Gomis i de Barbara
 
Appointments and remunerations committee
Chairman: Mr. Emilio Moraleda Martinez
Secretary: Mrs. Maria Luisa Francoli Plaza

Reig Jofre knows of no shareholders’ agreement between shareholders of the company.